A detailed history of Cva Family Office, LLC transactions in Viatris Inc stock. As of the latest transaction made, Cva Family Office, LLC holds 179 shares of VTRS stock, worth $2,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
179
Previous 177 1.13%
Holding current value
$2,079
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$10.32 - $12.13 $20 - $24
2 Added 1.13%
179 $2,000
Q2 2024

Jul 09, 2024

BUY
$10.05 - $12.02 $442 - $528
44 Added 33.08%
177 $1,000
Q1 2024

Apr 10, 2024

BUY
$11.27 - $13.53 $22 - $27
2 Added 1.53%
133 $1,000
Q4 2023

Jan 16, 2024

BUY
$8.77 - $10.85 $1,148 - $1,421
131 New
131 $1,000
Q2 2023

Jul 10, 2023

SELL
$9.02 - $10.29 $1,578 - $1,800
-175 Reduced 44.42%
219 $2,000
Q1 2023

Apr 26, 2023

BUY
$9.2 - $12.26 $1,334 - $1,777
145 Added 58.23%
394 $3,000
Q4 2022

Feb 21, 2023

SELL
$8.72 - $11.56 $1,892 - $2,508
-217 Reduced 46.57%
249 $2,000
Q3 2022

Nov 22, 2022

BUY
$8.48 - $11.13 $1,916 - $2,515
226 Added 94.17%
466 $4,000
Q2 2022

Jul 11, 2022

BUY
$9.95 - $12.27 $9 - $12
1 Added 0.42%
240 $3,000
Q1 2022

Apr 22, 2022

SELL
$9.81 - $15.4 $6,916 - $10,857
-705 Reduced 74.68%
239 $3,000
Q4 2021

Jan 25, 2022

BUY
$12.09 - $14.68 $11,412 - $13,857
944 New
944 $13,000
Q3 2021

Oct 12, 2021

SELL
$13.25 - $15.13 $10,666 - $12,179
-805 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$12.97 - $16.15 $544 - $678
42 Added 5.5%
805 $12,000
Q1 2021

Apr 14, 2021

BUY
$13.59 - $18.54 $67 - $92
5 Added 0.66%
763 $11,000
Q4 2020

Jan 15, 2021

BUY
$14.3 - $18.74 $10,839 - $14,204
758 New
758 $14,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.